5.95 USD
+0.03 (+0.51%)
5.8945 USD
-0.06 (-0.93%)
We assign a fundamental rating of 1 out of 10 to POAI. POAI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. POAI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, POAI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
POAI had negative earnings in the past year.
In the past year POAI has reported a negative cash flow from operations.
POAI had negative earnings in each of the past 5 years.
POAI had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -2688.13%, POAI is doing worse than 98.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2688.13% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-150.57%
ROA(5y)-139.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 50.26%, POAI is in line with its industry, outperforming 44.38% of the companies in the same industry.
POAI's Gross Margin has declined in the last couple of years.
POAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.14%
GM growth 5Y-4.67%
2. Health
2.1 Basic Checks
POAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for POAI has been increased compared to 1 year ago.
POAI has more shares outstanding than it did 5 years ago.
POAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -157.16, we must say that POAI is in the distress zone and has some risk of bankruptcy.
POAI has a Altman-Z score of -157.16. This is amonst the worse of the industry: POAI underperforms 96.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -157.16 |
ROIC/WACCN/A
WACC8.76%
2.3 Liquidity
POAI has a Current Ratio of 0.01. This is a bad value and indicates that POAI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.01, POAI is not doing good in the industry: 99.47% of the companies in the same industry are doing better.
POAI has a Quick Ratio of 0.01. This is a bad value and indicates that POAI is not financially healthy enough and could expect problems in meeting its short term obligations.
POAI has a Quick ratio of 0.01. This is amonst the worse of the industry: POAI underperforms 99.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.01 | ||
| Quick Ratio | 0.01 |
3. Growth
3.1 Past
POAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -163.00%.
POAI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -47.20%.
POAI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.86% yearly.
EPS 1Y (TTM)-163%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1379.27%
Revenue 1Y (TTM)-47.2%
Revenue growth 3Y4.57%
Revenue growth 5Y2.86%
Sales Q2Q%-98.96%
3.2 Future
The Earnings Per Share is expected to grow by 26.17% on average over the next years. This is a very strong growth
Based on estimates for the next years, POAI will show a very strong growth in Revenue. The Revenue will grow by 158.10% on average per year.
EPS Next Y99.58%
EPS Next 2Y41.51%
EPS Next 3Y26.17%
EPS Next 5YN/A
Revenue Next Year569.48%
Revenue Next 2Y232.87%
Revenue Next 3Y158.1%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for POAI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 72.92, the valuation of POAI can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of POAI indicates a somewhat cheap valuation: POAI is cheaper than 66.84% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.83. POAI is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 72.92 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
POAI's earnings are expected to grow with 26.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.51%
EPS Next 3Y26.17%
5. Dividend
5.1 Amount
POAI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
5.95
+0.03 (+0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.15%
Inst Owner Change-87.44%
Ins Owners3.21%
Ins Owner Change20.39%
Market Cap88.66M
Revenue(TTM)728.20K
Net Income(TTM)-84.33M
Analysts43.33
Price TargetN/A
Short Float %0.49%
Short Ratio1.41
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-99.79%
Min Revenue beat(2)-99.82%
Max Revenue beat(2)-99.76%
Revenue beat(4)1
Avg Revenue beat(4)-55.24%
Min Revenue beat(4)-99.82%
Max Revenue beat(4)71.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 72.92 | ||
| P/S | 121.75 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-120.64
EYN/A
EPS(NY)0.08
Fwd EY1.37%
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.05
BVpS-5.2
TBVpS-5.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2688.13% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.26% | ||
| FCFM | N/A |
ROA(3y)-150.57%
ROA(5y)-139.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.14%
GM growth 5Y-4.67%
F-Score4
Asset Turnover0.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 0% | ||
| Cap/Sales | 0% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.01 | ||
| Quick Ratio | 0.01 | ||
| Altman-Z | -157.16 |
F-Score4
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)20.65%
Cap/Depr(5y)33.78%
Cap/Sales(3y)11.77%
Cap/Sales(5y)26.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-163%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1379.27%
EPS Next Y99.58%
EPS Next 2Y41.51%
EPS Next 3Y26.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.2%
Revenue growth 3Y4.57%
Revenue growth 5Y2.86%
Sales Q2Q%-98.96%
Revenue Next Year569.48%
Revenue Next 2Y232.87%
Revenue Next 3Y158.1%
Revenue Next 5YN/A
EBIT growth 1Y21.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.91%
OCF growth 3YN/A
OCF growth 5YN/A
PREDICTIVE ONCOLOGY INC / POAI FAQ
What is the ChartMill fundamental rating of PREDICTIVE ONCOLOGY INC (POAI) stock?
ChartMill assigns a fundamental rating of 1 / 10 to POAI.
Can you provide the valuation status for PREDICTIVE ONCOLOGY INC?
ChartMill assigns a valuation rating of 2 / 10 to PREDICTIVE ONCOLOGY INC (POAI). This can be considered as Overvalued.
What is the profitability of POAI stock?
PREDICTIVE ONCOLOGY INC (POAI) has a profitability rating of 0 / 10.
Can you provide the financial health for POAI stock?
The financial health rating of PREDICTIVE ONCOLOGY INC (POAI) is 0 / 10.